Neomycin/polymyxin b/prednisolone ophthalmic Interactions
There are 51 drugs known to interact with neomycin/polymyxin b/prednisolone ophthalmic, along with 2 disease interactions. Of the total drug interactions, 1 is major, and 50 are moderate.
- View all 51 medications that may interact with neomycin/polymyxin b/prednisolone ophthalmic
- View neomycin/polymyxin b/prednisolone ophthalmic disease interactions (2)
Most frequently checked interactions
View interaction reports for neomycin / polymyxin b / prednisolone ophthalmic and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Aspir 81 (aspirin)
- Augmentin (amoxicillin / clavulanate)
- Azithromycin Dose Pack (azithromycin)
- Claritin (loratadine)
- CoQ10 (ubiquinone)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Depakote (divalproex sodium)
- Durezol (difluprednate ophthalmic)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Gas-X Extra Strength (simethicone)
- Humalog (insulin lispro)
- Imodium (loperamide)
- Keflex (cephalexin)
- Klonopin (clonazepam)
- Lantus (insulin glargine)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lipitor (atorvastatin)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Nexium (esomeprazole)
- Paracetamol (acetaminophen)
- Restasis (cyclosporine ophthalmic)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
Neomycin/polymyxin b/prednisolone ophthalmic disease interactions
There are 2 disease interactions with neomycin / polymyxin b / prednisolone ophthalmic which include:
More about neomycin / polymyxin b / prednisolone ophthalmic
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic steroids with anti-infectives
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.